- Home
- QNCX vs SQNS Comparison
QNCX vs SQNS Comparison
Compare QNCX & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SQNS
- Stock Information
- Founded
- QNCX 2012
- SQNS 2003
- Country
- QNCX United States
- SQNS France
- Employees
- QNCX N/A
- SQNS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SQNS Semiconductors
- Sector
- QNCX Health Care
- SQNS Technology
- Exchange
- QNCX Nasdaq
- SQNS Nasdaq
- Market Cap
- QNCX 47.7M
- SQNS 46.5M
- IPO Year
- QNCX 2019
- SQNS 2011
- Fundamental
- Price
- QNCX $1.68
- SQNS $1.42
- Analyst Decision
- QNCX Strong Buy
- SQNS Strong Buy
- Analyst Count
- QNCX 5
- SQNS 1
- Target Price
- QNCX $8.00
- SQNS $7.50
- AVG Volume (30 Days)
- QNCX 235.8K
- SQNS 14.4M
- Earning Date
- QNCX 08-12-2025
- SQNS 07-31-2025
- Dividend Yield
- QNCX N/A
- SQNS N/A
- EPS Growth
- QNCX N/A
- SQNS N/A
- EPS
- QNCX N/A
- SQNS 2.16
- Revenue
- QNCX N/A
- SQNS $38,858,000.00
- Revenue This Year
- QNCX N/A
- SQNS N/A
- Revenue Next Year
- QNCX N/A
- SQNS $83.38
- P/E Ratio
- QNCX N/A
- SQNS $0.70
- Revenue Growth
- QNCX N/A
- SQNS 40.06
- 52 Week Low
- QNCX $0.51
- SQNS $1.18
- 52 Week High
- QNCX $2.45
- SQNS $5.83
- Technical
- Relative Strength Index (RSI)
- QNCX 50.83
- SQNS 38.38
- Support Level
- QNCX $1.75
- SQNS $1.34
- Resistance Level
- QNCX $2.05
- SQNS $5.83
- Average True Range (ATR)
- QNCX 0.16
- SQNS 0.81
- MACD
- QNCX -0.02
- SQNS -0.24
- Stochastic Oscillator
- QNCX 9.76
- SQNS 0.90
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.